参考文献/References:
[1] Bugge K,Papaleo E,Haxholm GW,et al.A combined computational and structural model of the full-length human prolactin receptor[J].Nat Commun,2016,7:11578.DOI:10.1038/ncomms11578.
[2] Goffin V,Binart N,Touraine P,et al.Prolactin:the new biology of an old hormone[J].Annu Rev Physiol,2002,64:47-67.DOI:10.1146/annurev.physiol.64.081501.131049.
[3] Trott JF,Hovey RC,Koduri S,et al.Alternative splicing to exon 11 of human prolactin receptor gene results in multiple isoforms including a secreted prolactin-binding protein[J].J Mol Endocrinol,2003,30(1):31-47.DOI:10.1677/jme.0.0300031.
[4] Schennink A,Trott JF,Manjarin R,et al.Comparative genomics reveals tissue-specific regulation of prolactin receptor gene expression[J].J Mol Endocrinol,2015,54(1):1-15.DOI:10.1530/JME-14-0212.
[5] Harvey S,Arámburo C,Sanders EJ.Extrapituitary production of anterior pituitary hormones:an overview[J].Endocrine,2012,41(1):19-30.DOI:10.1007/s12020-011-9557-z.
[6] Peirce SK,Chen WY,Chen WY.Quantification of prolactin receptor mRNA in multiple human tissues and cancer cell lines by real time RT-PCR[J].J Endocrinol,2001,171(1):R1-4.DOI:10.1677/joe.0.171r001.
[7] Borba VV,Zandman-Goddard G,Shoenfeld Y.Prolactin and autoimmunity:the hormone as an inflammatory cytokine[J].Best Pract Res Clin Endocrinol Metab,2019,33(6):101324.DOI:10.1016/j.beem.2019.101324.
[8] Costa P,Catarino AL,Silva F,et al.Expression of prolactin receptor and prolactin in normal and malignant thyroid:a tissue microarray study[J].Endocr Pathol,2006,17(4):377-386.DOI:10.1007/s12022-006-0009-x.
[9] Do Amaral VC,Da Silva PL,Carvalho KC,et al.Effects of metoclopramide-induced hyperprolactinemia on the prolactin and prolactin receptor expression of murine adrenal[J].Gynecol Endocrinol,2015,31(12):925-928.DOI:10.3109/09513590.2015.1062863.
[10] Zhang P,Ge Z,Wang H,et al.Prolactin improves hepatic steatosis via CD36 pathway[J].J Hepatol,2018,68(6):1247-1255.DOI:10.1016/j.jhep.2018.01.035.
[11] Shao S,Yao Z,Lu J,et al.Ablation of prolactin receptor increases hepatic triglyceride accumulation[J].Biochem Biophys Res Commun,2018,498(3):693-699.DOI:10.1016/j.bbrc.2018.03.048.
[12] Paternostro R,Heinisch BB,Reiberger T,et al.Dysbalanced sex hormone status is an independent predictor of decompensation and mortality in patients with liver cirrhosis[J].Hepatol Res,2019,49(2):201-211.DOI:10.1111/hepr.13253.
[13] Ajibade DV,Dhawan P,Fechner AJ,et al.Evidence for a role of prolactin in calcium homeostasis:regulation of intestinal transient receptor potential vanilloid type 6,intestinal calcium absorption,and the 25-hydroxyvitamin D(3)1alpha hydroxylase gene by prolactin[J].Endocrinology,2010,151(7):2974-2984.DOI:10.1210/en.20 10-0033.
[14] Wu W,Sun M,Zhang HP,et al.Prolactin mediates psychological stress-induced dysfunction of regulatory T cells to facilitate intestinal inflammation[J].Gut,2014,63(12):1883-1892.DOI:10.1136/gutjnl-2013-306083.
[15] Tandon M,Coudriet GM,Criscimanna A,et al.Prolactin promotes fibrosis and pancreatic cancer progression[J].Cancer Res,2019,79(20):5316-5327.DOI:10.1158/0008-5472.CAN-18-3064.
[16] Dandawate P,Kaushik G,Ghosh C,et al.Diphenylbutylpiperidine antipsychotic drugs inhibit prolactin receptor signaling to reduce growth of pancreatic ductal adenocarcinoma in mice[J].Gastroenterology,2020,158(5):1433-1449.e27.DOI:10.1053/j.gastro.2019.11.279.
[17] Ascencio-Cedillo R,López-Pulido EI,Muñoz-Valle JF,et al.Prolactin and prolactin receptor expression in cervical intraepithelial neoplasia and cancer[J].Pathol Oncol Res,2015,21(2):241-246.DOI:10.1007/s12253-014-9814-6.
[18] Riera-Leal A,Ramírez De Arellano A,Ramírez-López IG,et al.Effects of 60 kDa prolactin and estradiol on metabolism and cell survival in cervical cancer:co-expression of their hormonal receptors during cancer progression[J].Oncol Rep,2018,40(6):3781-3793.DOI:10.3892/or.2018.6743.
[19] Sundaram KM,Zhang Y,Mitra AK,et al.Prolactin receptor-mediated internalization of imaging agents detects epithelial ovarian cancer with enhanced sensitivity and specificity[J].Cancer Res,2017,77(7):1684-1696.DOI:10.1158/0008-5472.CAN-16-1454.
[20] Karthikeyan S,Russo A,Dean M,et al.Prolactin signaling drives tumorigenesis in human high grade serous ovarian cancer cells and in a spontaneous fallopian tube derived model[J].Cancer Lette,2018,433:221-231.DOI:10.1016/j.canlet.2018.07.003.
[21] Samperi I,Lithgow K,Karavitaki N.Hyperprolactinaemia[J].J Clin Medic,2019,8(12):2203.DOI:10.3390/jcm8122203.
[22] Ewerman L,Landberg E,Hellberg S,et al.Immunomodulating effects depend on prolactin levels in patients with hyperprolactinemia[J].Horm Metab Res,2020,52(4):228-235.DOI:10.1055/a-1126-4272.
[23] Liu Y,Zhang Z,Jin Q,et al.Hyperprolactinemia is associated with a high prevalence of serum autoantibodies,high levels of inflammatory cytokines and an abnormal distribution of peripheral B-cell subsets[J].Endocrine,2019,64(3):648-656.DOI:10.1007/s12020-019-01896-y.
[24] Larouche V,Correa JA,Cassidy P,et al.Prevalence of autoimmune disease in patients with prolactinomas and non-functioning pituitary adenomas[J].Pituitary,2016,19(2):202-209.DOI:10.1007/s11102-015-0699-5.
[25] Borba VV,Zandman-Goddard G,Shoenfeld Y.Prolactin and autoimmunity[J].Front Immunol,2018,9:73.DOI:10.3389/fimmu.2018.00073.
[26] Freeman ME,Kanyicska B,Lerant A,et al.Prolactin:structure,function,and regulation of secretion[J].Physiol Rev,2000,80(4):1523-1631.DOI:10.1152/physrev.2000.80.4.1523.
[27] Brown RS,Wyatt AK,Herbison RE,et al.Prolactin transport into mouse brain is independent of prolactin receptor[J].FASEB J,2016,30(2):1002-1010.DOI:10.1096/fj.15-276519.
[28] Brown RSE,Aoki M,Ladyman SR,et al.Prolactin action in the medial preoptic area is necessary for postpartum maternal nursing behavior[J].Proc Natl Acad Sci U S A,2017,114(40):10779-10784.DOI:10.1073/pnas.1708025114.
[29] Cabrera-Reyes EA,Limón-Morales O,Rivero-Segura NA,et al.Prolactin function and putative expression in the brain[J].Endocrine,2017,57(2):199-213.DOI:10.1007/s12020-017-1346-x.
[30] Freemark M,Avril I,Fleenor D,et al.Targeted deletion of the PRL receptor:effects on islet development,insulin production,and glucose tolerance[J].Endocrinology,2002,143(4):1378-1385.DOI:10.1210/endo.143.4.8722.
[31] Banerjee RR,Cyphert HA,Walker EM,et al.Gestational diabetes mellitus from inactivation of prolactin receptor and MafB in islet β-cells[J].Diabetes,2016,65(8):2331-2341.DOI:10.2337/db15-1527.
[32] Auriemma RS,Alcubierre DD,Pirchio R,et al.Glucose abnormalities associated to prolactin secreting pituitary adenomas[J].Front Endocrinol,2019,10:327.DOI:10.3389/fendo.2019.00327.
[33] Lopez Vicchi F,Luque GM,Brie B,et al.Dopaminergic drugs in type 2 diabetes and glucose homeostasis[J].Pharmacol Res,2016,109:74-80.DOI:10.1016/j.phrs.2015.12.029.
[34] Chen H,Kleinberger JW,Takane KK,et al.Augmented Stat5 signaling bypasses multiple impediments to lactogen-mediated proliferation in human β-cells[J].Diabetes,2015,64(11):3784-3797.DOI:10.2337/db15-0083.
[35] Di Filippo L,Doga M,Resmini E,et al.Hyperprolactinemia and bone[J].Pituitary,2020,23(3):314-321.DOI:10.1007/s11102-020-01041-3.
[36] Mazziotti G,Porcelli T,Mormando M,et al.Vertebral fractures in males with prolactinoma[J].Endocrine,2011,39(3):288-293.DOI:10.1007/s12020-011-9462-5.
[37] Mazziotti G,Mancini T,Mormando M,et al.High prevalence of radiological vertebral fractures in women with prolactin-secreting pituitary adenomas[J].Pituitary,2011,14(4):299-306.DOI:10.1007/s11102-011-0293-4.
[38] Winter EM,Appelman-Dijkstra NM.Parathyroid hormone-related protein-induced hypercalcemia of pregnancy successfully reversed by a dopamine agonist[J].J Clin Endocrinol Metab,2017,102(12):4417-4420.DOI:10.1210/jc.2017-01617.
[39] Perez Millan MI,Luque GM,Ramirez MC,et al.Selective disruption of dopamine D2 receptors in pituitary lactotropes increases body weight and adiposity in female mice[J].Endocrinology,2014,155(3):829-839.DOI:10.1210/en.2013-1707.
[40] Sobrinho LG,Horseman ND.Prolactin and human weight disturbances:a puzzling and neglected association[J].Rev Endocr Metab Disord,2019,20(2):197-206. DOI:10.1007/s11154-019-09503-1.
[41] Atis G,Dalkilinc A,Altuntas Y,et al.Sexual dysfunction in women with clinical hypothyroidism and subclinical hypothyroidism[J].J Sex Med,2010,7(7):2583-2590.DOI:10.1111/j.1743-6109.2010.01815.x.
[42] Shrestha S,Neupane S,Gautam N,et al.Association of thyroid profile and prolactin level in patient with secondary amenorrhea[J].Malays J Med Sci,2016,23(5):51-56.DOI:10.21315/mjms2016.23.5.7.